Position in VIR
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$10,176,436
+$3,955,509 QoQ
Shares Held
1,135,763
+10.1% QoQ
Ownership
0.673%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. VIR ranks #55 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
186,388 | $144,010,824 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,915 | $102,219,704 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
259,731 | $77,132,315 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
224,330 | $74,224,067 | |
| 5 | INSM |
INSMED Inc
|
401,735 | $65,691,707 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,516,297 | $58,362,271 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
580,677 | $56,470,838 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,001,976 | $55,454,735 |
All Filings in VIR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,176,436 | 1,135,763 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,220,927 | 1,031,663 | Shares | Sole | 2026-04-30 | |
| 2023-09-30 | $103,313 | 11,026 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,699,441 | 354,645 | Shares | Sole | 2023-08-08 | |
| 2021-03-31 | $11,599,222 | 226,238 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $6,058,653 | 226,238 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $7,059,003 | 205,622 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||